Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workersResearch Published on 2024-08-012024-09-05 Journal: BMC Infectious Diseases [Category] update2024, [키워드] CoronaVac COVID-19 Humoral immunity mRNA-1273 SARS-CoV-2 [DOI] 10.1186/s12879-024-09644-y PMC 바로가기 [Article Type] Research
Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of BoosterArticle Published on 2024-07-182024-09-05 Journal: Vaccines [Category] update2024, [키워드] Anti-RBD antibodies BNT162b2 ChAdOx1-S CoronaVac COVID-19 dose booster Neutralizing antibodies study longitudinal vaccine effectiveness [DOI] 10.3390/vaccines12070792 PMC 바로가기 [Article Type] Article
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac –inactivated COVID-19 vaccinesCoronavirus Published on 2024-06-262024-09-05 Journal: Human vaccines & immunotherapeutics [Category] update2024, [키워드] adverse events CoronaVac COVID-19 inactive COVID-19 vaccine previous infection Safety TURKOVAC [DOI] 10.1080/21645515.2024.2346388 PMC 바로가기 [Article Type] Coronavirus
Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side EffectReview Published on 2024-06-252024-09-05 Journal: Vaccines [Category] update2024, [키워드] Acquired hemophilia A BNT162b2 CoronaVac COVID-19 Inactivated vaccine mRNA vaccines mRNA-1273 SARS-CoV-2 Vaccine Vaxzevria Viral vector vaccine [DOI] 10.3390/vaccines12070709 PMC 바로가기 [Article Type] Review
Clinical outcomes and risk factors for SARS-CoV-2 breakthrough cases following vaccination with BNT162b2, CoronaVac, or ChAdOx1-S: A retrospective cohort study in MalaysiaResearch Article Published on 2024-04-202024-09-05 Journal: Heliyon [Category] update2024, [키워드] BNT162b2 Breakthrough infection ChAdOx1-S CoronaVac COVID-19 COVID-19 vaccines SARS-CoV-2 [DOI] 10.1016/j.heliyon.2024.e29574 PMC 바로가기 [Article Type] Research Article
Immune Response to an Inactivated Vaccine of SARS-CoV-2 (CoronaVac) in an Indigenous Brazilian Population: A Cohort StudyArticle Published on 2024-04-102024-09-05 Journal: Vaccines [Category] update2024, [키워드] CoronaVac immune response SARS-CoV-2 Vaccine [DOI] 10.3390/vaccines12040402 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipientsResearch Article Published on 2024-04-082024-09-05 Journal: mBio [Category] update2024, [키워드] B cells CoronaVac IgA immune imprinting Omicron BA.5 T cells [DOI] 10.1128/mbio.02407-23 PMC 바로가기 [Article Type] Research Article
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 InfectionArticle Published on 2024-02-102024-09-05 Journal: Vaccines [Category] update2024, [키워드] ChAdOx1 CoronaVac COVID-19 Durability Hybrid immunity Long-term follow-up omicron previous infection SARS-CoV-2 [DOI] 10.3390/vaccines12020180 PMC 바로가기 [Article Type] Article
SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccinesCoronavirus Published on 2024-01-112024-09-05 Journal: Human vaccines & immunotherapeutics [Category] update2024, [키워드] Comirnaty CoronaVac COVID-19 Delta heterologous booster homologous booster omicron SCB-2019 Vaccine Vaxzevria [DOI] 10.1080/21645515.2023.2301632 PMC 바로가기 [Article Type] Coronavirus
Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong KongResearch Published on 2024-01-012024-09-05 Journal: Emerging Infectious Diseases [Category] update2024, [키워드] Comirnaty CoronaVac coronavirus coronavirus disease COVID-19 Hong Kong molnupiravir Nirmatrelvir respiratory infections Ritonavir SARS SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 viruses zoonoses [DOI] 10.3201/eid3001.230414 PMC 바로가기 [Article Type] Research